This multicenter, randomized, parallel-group clinical trial aims to evaluate the efficacy of acupuncture combined with adjuvant chemotherapy in patients with gastric cancer who have undergone surgery. Participants will be randomly assigned in a 1:1 ratio to receive either acupuncture or sham acupuncture during the adjuvant chemotherapy period.
Patients with gastric cancer who have undergone R0 resection of the stomach/ distal stomach with D2 lymphadenectomy and are planned to receive postoperative adjuvant chemotherapy
Postoperative pathological diagnosis of gastric cancer, with pathological staging of pII/pIII (American Joint Committee on Cancer, AJCC)
No recurrence or metastasis confirmed by imaging examination
Performance Status (PS) score of 0-2
Unable to complete baseline assessment
Individuals with a fear of acupuncture
Those planning to receive postoperative adjuvant radiotherapy
History of blood system diseases, organ transplant history, or those requiring long-term oral immunosuppressants
Guangzhou University of Traditional Chinese Medicine
Lead sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Collaborator
First Affiliated Hospital, Sun Yat-Sen University
Collaborator